Sienna Biopharmaceuticals, Inc. (SNNAQ)
0.0000
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Sienna Biopharmaceuticals Cash from Operations (TTM)
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| September 30, 2019 | -54.64M |
| June 30, 2019 | -52.69M |
| March 31, 2019 | -60.02M |
| December 31, 2018 | -61.69M |
| Date | Value |
|---|---|
| September 30, 2018 | -60.18M |
| June 30, 2018 | -53.69M |
| March 31, 2018 | -49.46M |
| December 31, 2017 | -41.01M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| ANI Pharmaceuticals, Inc. | 189.47M |
| Corcept Therapeutics, Inc. | 109.70M |
| Veru, Inc. | -26.04M |
| Johnson & Johnson | 27.61B |
| Eli Lilly & Co. | 28.08B |